{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:44:36Z","timestamp":1792658676322,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40478-018-0540-2","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T13:28:33Z","timestamp":1527859713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"6","author":[{"given":"David C.","family":"Hondius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel N.","family":"Eigenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjado H. J.","family":"Morrema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel C.","family":"van der Schors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim","family":"van Nierop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Bugiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Wan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J. M.","family":"Hoozemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"August B.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke J. M.","family":"Rozemuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"key":"540_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2990.2010.01137.x","volume":"37","author":"J Attems","year":"2011","unstructured":"Attems J, Jellinger K, Thal DR, Van Nostrand W (2011) Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 37:75\u201393. \n                    https:\/\/doi.org\/10.1111\/j.1365-2990.2010.01137.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"540_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","volume":"115","author":"D Rudolf Thal","year":"2008","unstructured":"Rudolf Thal D, Sue GriYn WT, I de Vos RA, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer\u2019s disease. Acta Neuropathol 115:599\u2013609. \n                    https:\/\/doi.org\/10.1007\/s00401-008-0366-2","journal-title":"Acta Neuropathol"},{"key":"540_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00401-005-1074-9","volume":"110","author":"J Attems","year":"2005","unstructured":"Attems J (2005) Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol 110:345\u2013359. \n                    https:\/\/doi.org\/10.1007\/s00401-005-1074-9","journal-title":"Acta Neuropathol"},{"key":"540_CR4","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1097\/NEN.0b013e3181fab558","volume":"69","author":"E Richard","year":"2010","unstructured":"Richard E, Carrano A, Hoozemans JJ, Van Horssen J, Van Haastert ES, Eurelings LS, De Vries HE, Thal DR, Eikelenboom P, Van Gool WA, Rozemuller AJM (2010) Characteristics of dyshoric capillary cerebral amyloid angiopathy. J Neuropathol Exp Neurol 69:1158\u20131167. \n                    https:\/\/doi.org\/10.1097\/NEN.0b013e3181fab558","journal-title":"J Neuropathol Exp Neurol"},{"key":"540_CR5","doi-asserted-by":"publisher","unstructured":"van Veluw SJ, Kuijf HJ, Charidimou A, Viswanathan A, Biessels GJ, Rozemuller AJM, Frosch MP, Greenberg SM (2016) Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy. Acta Neuropathol:1\u20137. \n                    https:\/\/doi.org\/10.1007\/s00401-016-1635-0","DOI":"10.1007\/s00401-016-1635-0"},{"key":"540_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1179\/016164103101202057","volume":"25","author":"RO Weller","year":"2003","unstructured":"Weller RO, Nicoll J a R (2003) Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain. Neurol Res 25:611\u2013616. \n                    https:\/\/doi.org\/10.1179\/016164103101202057","journal-title":"Neurol Res"},{"key":"540_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10571-015-0273-8","volume":"36","author":"ENTP Bakker","year":"2016","unstructured":"Bakker ENTP, Bacskai BJ, Arbel-Ornath M, Aldea R, Bedussi B, Morris AWJ, Weller RO, Carare RO (2016) Lymphatic clearance of the brain: perivascular, Paravascular and significance for neurodegenerative diseases. Cell Mol Neurobiol 36:181\u2013194. \n                    https:\/\/doi.org\/10.1007\/s10571-015-0273-8","journal-title":"Cell Mol Neurobiol"},{"key":"540_CR8","first-page":"253","volume-title":"Brain Pathol","author":"RO Weller","year":"2008","unstructured":"Weller RO, Subash M, Preston SD, Mazanti I, Carare RO (2008) Perivascular drainage of amyloid-?? Peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease. In: Brain Pathol, pp 253\u2013266"},{"key":"540_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00401-003-0796-9","volume":"107","author":"J Attems","year":"2004","unstructured":"Attems J, Jellinger KA (2004) Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology?A pilot study. Acta Neuropathol 107:83\u201390. \n                    https:\/\/doi.org\/10.1007\/s00401-003-0796-9","journal-title":"Acta Neuropathol"},{"key":"540_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jns.2010.04.020","volume":"295","author":"LSM Eurelings","year":"2010","unstructured":"Eurelings LSM, Richard E, Carrano A, Eikelenboom P, van Gool WA, Rozemuller AJM (2010) Dyshoric capillary cerebral amyloid angiopathy mimicking Creutzfeldt\u2013Jakob disease. J Neurol Sci 295:131\u2013134. \n                    https:\/\/doi.org\/10.1016\/j.jns.2010.04.020","journal-title":"J Neurol Sci"},{"key":"540_CR11","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1093\/jnen\/62.12.1287","volume":"62","author":"DR Thal","year":"2003","unstructured":"Thal DR, Ghebremedhin E, Orantes M, Wiestler OD (2003) Vascular pathology in Alzheimer disease: correlation of cerebral amyloid Angiopathy and arteriosclerosis\/Lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol 62:1287\u20131301. \n                    https:\/\/doi.org\/10.1093\/jnen\/62.12.1287","journal-title":"J Neuropathol Exp Neurol"},{"key":"540_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"540_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer\u2019s disease (CERAD): part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013479. \n                    https:\/\/doi.org\/10.1212\/WNL.41.4.479","journal-title":"Neurology"},{"key":"540_CR14","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u00fcb U, Orantes M, Braak H (2002) Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800. \n                    https:\/\/doi.org\/10.1212\/WNL.58.12.1791","journal-title":"Neurology"},{"key":"540_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT (2012) National institute on aging-Alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311. \n                    https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"540_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/13506129.2013.797389","volume":"20","author":"NA Verwey","year":"2013","unstructured":"Verwey NA, Hoozemans JJM, Korth C, van Royen MR, Prikulis I, Wouters D, HAM T, van Haastert ES, Schenk D, Scheltens P, Rozemuller AJM, Blankenstein MA, Veerhuis R (2013) Immunohistochemical characterization of novel monoclonal antibodies against the N-terminus of amyloid \u03b2-peptide. Amyloid 20:179\u2013187. \n                    https:\/\/doi.org\/10.3109\/13506129.2013.797389","journal-title":"Amyloid"},{"key":"540_CR17","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jalz.2015.11.002","volume":"12","author":"DC Hondius","year":"2016","unstructured":"Hondius DC, Van Nierop P, Li KW, Hoozemans JJM, Van Der Schors RC, Van Haastert ES, Van Der Vies SM, Rozemuller AJM, Smit AB (2016) Profiling the human hippocampal proteome at all pathologic stages of Alzheimer\u2019s disease. Alzheimers Dement 12:654\u2013668. \n                    https:\/\/doi.org\/10.1016\/j.jalz.2015.11.002","journal-title":"Alzheimers Dement"},{"key":"540_CR18","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.P.B.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26:1367\u20131372. \n                    https:\/\/doi.org\/10.1038\/nbt.1511","journal-title":"Nat Biotechnol"},{"key":"540_CR19","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M (2014) Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13:2513\u20132526. \n                    https:\/\/doi.org\/10.1074\/mcp.M113.031591","journal-title":"Mol Cell Proteomics"},{"key":"540_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, Mann M, Cox J (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13:731\u2013740. \n                    https:\/\/doi.org\/10.1038\/nmeth.3901","journal-title":"Nat Methods"},{"key":"540_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ana.22112","volume":"69","author":"Z Arvanitakis","year":"2011","unstructured":"Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA (2011) Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 69:320\u2013327. \n                    https:\/\/doi.org\/10.1002\/ana.22112","journal-title":"Ann Neurol"},{"key":"540_CR22","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","volume":"85","author":"PA Boyle","year":"2015","unstructured":"Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA, Schneider JA (2015) Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology 85:1930\u20131936. \n                    https:\/\/doi.org\/10.1212\/WNL.0000000000002175","journal-title":"Neurology"},{"key":"540_CR23","doi-asserted-by":"publisher","unstructured":"Manousopoulou A, Gatherer M, Smith C, Nicoll JAR, Woelk CH, Johnson M, Kalaria R, Attems J, Garbis SD, Carare RO (2016) Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy. Neuropathol Appl Neurobiol. \n                    https:\/\/doi.org\/10.1111\/nan.12342","DOI":"10.1111\/nan.12342"},{"key":"540_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s004010050944","volume":"96","author":"MM Verbeek","year":"1998","unstructured":"Verbeek MM, Otte-H\u00f6ller I, Veerhuis R, Ruiter DJ, De Waal RMW (1998) Distribution of A\u03b2-associated proteins in cerebrovascular amyloid of Alzheimer\u2019s disease. Acta Neuropathol 96:628\u2013636. \n                    https:\/\/doi.org\/10.1007\/s004010050944","journal-title":"Acta Neuropathol"},{"key":"540_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/1055-8330(95)90018-7","volume":"4","author":"SS Zhan","year":"1995","unstructured":"Zhan SS, Veerhuis R, Kamphorst W, Eikelenboom P (1995) Distribution of beta amyloid associated proteins in plaques in Alzheimer\u2019s disease and in the non-demented elderly. Neurodegeneration 4:291\u2013297","journal-title":"Neurodegeneration"},{"key":"540_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s12017-015-8381-7","volume":"18","author":"A Monta\u00f1ola","year":"2016","unstructured":"Monta\u00f1ola A, de Retana SF, L\u00f3pez-Rueda A, Merino-Zamorano C, Penalba A, Fern\u00e1ndez-\u00c1lvarez P, Rodr\u00edguez-Luna D, Malagelada A, Pujadas F, Montaner J, Hern\u00e1ndez-Guillamon M (2016) ApoA1, ApoJ and ApoE plasma levels and genotype frequencies in cerebral amyloid Angiopathy. NeuroMolecular Med 18:99\u2013108. \n                    https:\/\/doi.org\/10.1007\/s12017-015-8381-7","journal-title":"NeuroMolecular Med"},{"key":"540_CR27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/nan.12342","volume":"43","author":"A Manousopoulou","year":"2017","unstructured":"Manousopoulou A, Gatherer M, Smith C, Nicoll JAR, Woelk CH, Johnson M, Kalaria R, Attems J, Garbis SD, Carare RO (2017) Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 43:492\u2013504. \n                    https:\/\/doi.org\/10.1111\/nan.12342","journal-title":"Neuropathol Appl Neurobiol"},{"key":"540_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00401-017-1720-z","volume":"134","author":"Y Inoue","year":"2017","unstructured":"Inoue Y, Ueda M, Tasaki M, Takeshima A, Nagatoshi A, Masuda T, Misumi Y, Kosaka T, Nomura T, Mizukami M, Matsumoto S, Yamashita T, Takahashi H, Kakita A, Ando Y (2017) Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy. Acta Neuropathol 134:605\u2013617. \n                    https:\/\/doi.org\/10.1007\/s00401-017-1720-z","journal-title":"Acta Neuropathol"},{"key":"540_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00441-014-1811-2","volume":"355","author":"B Engelhardt","year":"2014","unstructured":"Engelhardt B, Liebner S (2014) Novel insights into the development and maintenance of the blood\u2013brain barrier. Cell Tissue Res 355:687\u2013699. \n                    https:\/\/doi.org\/10.1007\/s00441-014-1811-2","journal-title":"Cell Tissue Res"},{"key":"540_CR30","doi-asserted-by":"publisher","unstructured":"Ye X, Smallwood P, Nathans J (2011) Expression of the Norrie disease gene (Ndp) in developing and adult mouse eye, ear, and brain. Gene Expr Patterns. \n                    https:\/\/doi.org\/10.1016\/j.gep.2010.10.007","DOI":"10.1016\/j.gep.2010.10.007"},{"key":"540_CR31","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0092-8674(04)00216-8","volume":"116","author":"Q Xu","year":"2004","unstructured":"Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, Woods C, Kelley MW, Jiang L, Tasman W, Zhang K, Nathans J (2004) Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 116:883\u2013895. \n                    https:\/\/doi.org\/10.1016\/S0092-8674(04)00216-8","journal-title":"Cell"},{"key":"540_CR32","doi-asserted-by":"publisher","unstructured":"Sproul AA, Jacob S, Pre D, Kim SH, Nestor MW, Navarro-Sobrino M, Santa-Maria I, Zimmer M, Aubry S, Steele JW, Kahler DJ, Dranovsky A, Arancio O, Crary JF, Gandy S, Noggle SA (2014) Characterization and molecular profiling of PSEN1 familial alzheimer\u2019s disease iPSC-derived neural progenitors. PLoS One. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0084547","DOI":"10.1371\/journal.pone.0084547"},{"key":"540_CR33","doi-asserted-by":"crossref","unstructured":"Ohlmann A, Seitz R, Braunger B, Seitz D, B\u00f6sl MR, Tamm ER (2010) Norrin promotes vascular regrowth after oxygen-induced retinal vessel loss and suppresses retinopathy in mice. J Neurosci 30","DOI":"10.1523\/JNEUROSCI.3210-09.2010"},{"key":"540_CR34","doi-asserted-by":"publisher","unstructured":"Braunger BM, Tamm ER (2012) The different functions of Norrin. Adv Exp med biol. \n                    https:\/\/doi.org\/10.1007\/978-1-4614-0631-0_86","DOI":"10.1007\/978-1-4614-0631-0_86"},{"key":"540_CR35","volume-title":"NDP-related retinopathies","author":"KB Sims","year":"1993","unstructured":"Sims KB (1993) NDP-related retinopathies. University of Washington, Seattle"},{"key":"540_CR36","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.1523\/JNEUROSCI.0730-10.2010","volume":"30","author":"R Seitz","year":"2010","unstructured":"Seitz R, Hackl S, Seibuchner T, Tamm ER, Ohlmann A (2010) Norrin mediates neuroprotective effects on retinal ganglion cells via activation of the Wnt\/-catenin signaling pathway and the induction of neuroprotective growth factors in Muller cells. J Neurosci 30:5998\u20136010. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0730-10.2010","journal-title":"J Neurosci"},{"key":"540_CR37","doi-asserted-by":"publisher","first-page":"a004978","DOI":"10.1101\/cshperspect.a004978","volume":"3","author":"S Ricard-Blum","year":"2011","unstructured":"Ricard-Blum S (2011) The collagen family. Cold Spring Harb Perspect Biol 3:a004978\u2013a004978. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a004978","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"540_CR38","doi-asserted-by":"publisher","first-page":"26522","DOI":"10.1074\/jbc.272.42.26522","volume":"272","author":"HJ Kuo","year":"1997","unstructured":"Kuo HJ, Maslen CL, Keene DR, Glanville RW (1997) Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem 272:26522\u201326529","journal-title":"J Biol Chem"},{"key":"540_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nn.2240","volume":"12","author":"JS Cheng","year":"2009","unstructured":"Cheng JS, Dubal DB, Kim DH, Legleiter J, Cheng IH, Yu G-Q, Tesseur I, Wyss-Coray T, Bonaldo P, Mucke L (2009) Collagen VI protects neurons against Abeta toxicity. Nat Neurosci 12:119\u2013121. \n                    https:\/\/doi.org\/10.1038\/nn.2240","journal-title":"Nat Neurosci"},{"key":"540_CR40","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1073\/pnas.0501823102","volume":"102","author":"S Grau","year":"2005","unstructured":"Grau S, Baldi A, Bussani R, Tian X, Stefanescu R, Przybylski M, Richards P, Jones SA, Shridhar V, Clausen T, Ehrmann M (2005) Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proc Natl Acad Sci 102:6021\u20136026. \n                    https:\/\/doi.org\/10.1073\/pnas.0501823102","journal-title":"Proc Natl Acad Sci"},{"key":"540_CR41","doi-asserted-by":"publisher","first-page":"9473","DOI":"10.1021\/jacs.6b03463","volume":"138","author":"Q Chu","year":"2016","unstructured":"Chu Q, Diedrich JK, Vaughan JM, Donaldson CJ, Nunn MF, Lee K-F, Saghatelian A (2016) HtrA1 proteolysis of ApoE in vitro is allele selective. J Am Chem Soc 138:9473\u20139478. \n                    https:\/\/doi.org\/10.1021\/jacs.6b03463","journal-title":"J Am Chem Soc"},{"key":"540_CR42","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1056\/NEJMoa0801560","volume":"360","author":"K Hara","year":"2009","unstructured":"Hara K, Shiga A, Fukutake T, Nozaki H, Miyashita A, Yokoseki A, Kawata H, Koyama A, Arima K, Takahashi T, Ikeda M, Shiota H, Tamura M, Shimoe Y, Hirayama M, Arisato T, Yanagawa S, Tanaka A, Nakano I, Ikeda S, Yoshida Y, Yamamoto T, Ikeuchi T, Kuwano R, Nishizawa M, Tsuji S, Onodera O (2009) Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med 360:1729\u20131739. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0801560","journal-title":"N Engl J Med"},{"key":"540_CR43","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/bpa.12181","volume":"24","author":"S Tikka","year":"2014","unstructured":"Tikka S, Baumann M, Siitonen M, Pasanen P, P\u00f6yh\u00f6nen M, Myllykangas L, Viitanen M, Fukutake T, Cognat E, Joutel A, Kalimo H (2014) CADASIL and CARASIL. Brain Pathol 24:525\u2013544. \n                    https:\/\/doi.org\/10.1111\/bpa.12181","journal-title":"Brain Pathol"},{"key":"540_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hup.823","volume":"22","author":"E Tumini","year":"2007","unstructured":"Tumini E, Porcellini E, Chiappelli M, Conti CM, Beraudi A, Poli A, Caciagli F, Doyle R, Conti P, Licastro F (2007) The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer\u2019s disease patients. Hum Psychopharmacol Clin Exp 22:75\u201380. \n                    https:\/\/doi.org\/10.1002\/hup.823","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"540_CR45","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.1093\/hmg\/ddu372","volume":"23","author":"A Ramirez","year":"2014","unstructured":"Ramirez A, van der Flier WM, Herold C, Ramonet D, Heilmann S, Lewczuk P, Popp J, Lacour A, Drichel D, Louwersheimer E, Kummer MP, Cruchaga C, Hoffmann P, Teunissen C, Holstege H, Kornhuber J, Peters O, Naj AC, Chouraki V, Bellenguez C, Gerrish A, Heun R, Frolich L, Hull M, Buscemi L, Herms S, Kolsch H, Scheltens P, Breteler MM, Ruther E, Wiltfang J, Goate A, Jessen F, Maier W, Heneka MT, Becker T, Nothen MM (2014) SUCLG2 identified as both a determinator of CSF a 1-42 levels and an attenuator of cognitive decline in Alzheimer\u2019s disease. Hum Mol Genet 23:6644\u20136658. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddu372","journal-title":"Hum Mol Genet"},{"key":"540_CR46","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1093\/brain\/awn261","volume":"131","author":"D Boche","year":"2008","unstructured":"Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, Holmes C, Nicoll JAR (2008) Consequence of Abeta immunization on the vasculature of human Alzheimer\u2019s disease brain. Brain 131:3299\u20133310. \n                    https:\/\/doi.org\/10.1093\/brain\/awn261","journal-title":"Brain"},{"key":"540_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","volume":"11","author":"R Sperling","year":"2012","unstructured":"Sperling R, Salloway S, Brooks DJ, Tampieri D, Barakos J, Fox NC, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Lieberburg I, Arrighi HM, Morris KA, Lu Y, Liu E, Gregg KM, Brashear HR, Kinney GG, Black R, Grundman M (2012) Amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol 11:241\u2013249. \n                    https:\/\/doi.org\/10.1016\/S1474-4422(12)70015-7","journal-title":"Lancet Neurol"},{"key":"540_CR48","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1136\/jnnp-2016-314697","volume":"88","author":"G Banerjee","year":"2017","unstructured":"Banerjee G, Carare R, Cordonnier C, Greenberg SM, Schneider JA, Smith EE, Van Buchem M, Van Der Grond J, Verbeek MM, Werring DJ (2017) The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. J Neurol Neurosurg Psychiatry 88:982\u2013994. \n                    https:\/\/doi.org\/10.1136\/jnnp-2016-314697","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-018-0540-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-018-0540-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T23:18:52Z","timestamp":1559603932000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-018-0540-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["540"],"URL":"https:\/\/doi.org\/10.1186\/s40478-018-0540-2","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]},"assertion":[{"value":"22 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A selection of proteins including, but not limited to, NDP, CLU, APOE, HTRA1, APCS, COL6A2 and COL6A3 are part of the patent application P113281EP00.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"46"}}